Genetic modification of liver grafts with an adenoviral vector encoding the Bcl-2 gene improves organ preservation

Transplantation

Volumn 67, Issue 6, 1999, Pages 775-783

  Bilbao, Guadalupe ^a   Contreras, Juan L ^a   Gómez Navarro, Jesús ^a   Eckhoff, Devin E ^a   Mikheeva, Galina ^a   Krasnykh, Victor ^a   Hynes, Tracy ^a   Thomas, Francis T ^a   Thomas, Judith M ^a   Curiel, David T ^a,b  

^a Kentucky   (United States)

^b Gene Therapy Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; GENE THERAPY; LIVER FUNCTION; LIVER TRANSPLANTATION; MOUSE; NONHUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL;

EID: 0033608763     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199903270-00001     Document Type: Article

References (57)

1. Adam R, Bismuth H, Diamond T, et al. Effect of extended cold ischemia with UW solution on graft function after liver transplantation. Lancet 1992; 340: 1373.
2. Howard TK, Klintmalm GB, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 1990; 49: 103.
3. Sanchez-Urdazpal L, Gores GJ, Ward EM, et al. Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology 1992; 16: 49.
4. Blankensteijn JD, Terpstra OT. Liver preservation: the past and the future. Hepatology 1991; 13: 1235.
5. Tamaki T, Okouchi Y, Kozaki M, Kawamura A, Uchino J, Pegg DE. Hypothermic preservation of the rat liver assessed by orthotopic transplantation. III. Improved functional recovery with isotonic citrate solution and a stable prostacyclin analogue. Transplantation 1988; 46: 626.
6. Furukawa H, Todo S, Imventarza O, et al. Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation 1991; 51: 1000.
7. Ploeg RJ, D'Alessandro Am, Hoffmann RM, et al. Impact of donor factors and preservation on function and survival after liver transplantation. Transplant Proc 1993; 25: 3031.
8. Jaeschke H. Preservation injury: mechanisms, prevention and consequences. J Hepatol 1996; 25: 774.
9. Strasberg SM. Preservation injury and donor selection: it all starts here. Liver Transpl Surg 1997; 3 (5 suppl 1): S1.
10. Kim SK, Belzer FO, Southard JH. Loss of mitochondrial respiratory function and its suppression during cold ischemic preservation of rat livers with University of Wisconsin solution. Hepatology 1992; 16: 742.
11. Borghi-Scoazec G, Scoazec JY, Durand F, et al. Apoptosis after ischemia-reperfusion in human liver allografts. Liver Transplant Surg 1997; 3: 407.
12. Patel T, Gores GJ. Apoptosis in liver transplantation: a mechanism contributing to immune modulation, preservation injury, neoplasia, and viral disease. Liver Transplant Surg 1998; 4: 42.
13. Sasaki H, Matsuno T, Ishikawa T, et al. Activation of apoptosis during early phase of reperfusion after liver transplantation. Transplant Proc 1997; 29: 406.
14. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997; 3: 614.
15. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA. 1996; 93: 2239.
16. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456.
17. Lawrence MS, Ho DY, Sun GH, Steinberg GK, Sapolsky RM. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosći 1996; 16: 486.
18. Zhong LT, Sarafian T, Kane DJ, et al. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA. 1993; 90: 4533.
19. Martinou JC, Dubois-Dauphin M, Staple JK, et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994; 13: 1017.
20. Garcia I, Martinou I, Tsujimoto Y, Martinou JC. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 1992; 258: 302.
21. Shimazaki K, Ishida A, Kawai N. Increase in bcl-2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus. Neurosci Res 1994; 20: 95.
22. Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H, Tsujimoto Y. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 1995; 374: 811.
23. Shimizu S, Eguchi Y, Kamiike W, et al. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res 1996; 56: 2161.
24. Jaffe HA, Danel C, Longenecker G, et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet 1992; 1: 372.
25. Gao GP, Yang Y, Wilson JM. Biology of adenovirus vectors with E1 and E4 deletions for liver- directed gene therapy. J Virol 1996; 70: 8934.
26. Tsukamoto K, Smith P, Glick JM, Rader DJ. Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice. J Clin Invest 1997; 100: 107.
27. Wang Q, Greenburg G, Bunch D, Farson D, Finer MH. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector. Gene Ther 1997; 4: 393.
28. Hitt MM, Addison CL, Graham FL. Human adenovirus vectors for gene transfer into mammalian cells. In: August JT, ed. Gene Therapy, London: Academic Press 1997; 1: 137.
29. Devlin J, Dunne JB, Sherwood RA, et al. Relationship between early liver graft viability and enzyme activities in effluent preservation solution. Transplantation 1995; 60: 627.
30. Hamamoto I, Takaya S, Todo S, et al. Can adenine nucleotides predict primary nonfunction of the human liver homograft? Transpl Int 1994; 7: 89.
31. Vrancken Peeters MJ, Patjin GA, Lieber A, Meuse L, Kay MA. Adenovirus-mediated hepatic gene transfer in mice: comparison of intravascular and biliary administration. Hum Gene Ther 1996; 7: 1693.
32. Vrancken Peeters MJ, Lieber A, Perkins J, Kay MA. Method of multiple poral vein infusions in mice: quantification of adenovirus-mediated hepatic gene transfer. BioTechniques 1996; 20: 278.
33. Ikeda T, Yanaga K, Kishikawa K, Kakizoe S, Shimada M, Sugimachi K. Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology 1992; 16: 454.
34. Jooss K, Yang Y, Wilson JM. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Hum Gene Ther 1996; 7: 1555.
35. Tzung SP, Fausto N, Hockenbery DM. Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene. Am J Pathol 1997; 150: 1985.
36. Yamamoto H, Ohdan H, Shintaku S, Asahara T, Ito H, Dohi K. Analysis of apoptosis-associated genes: Fas ligand, bcl-2 and bax in the rat liver allograft. Transplant Proc 1998; 30: 22.
37. Kurosawa H, Que FG, Roberts LR, Fesmier PJ, Gores GJ. Hepatocytes in the bile duct-ligated rat express Bcl-2. Am J Physiol 1997; 272: G1587.
38. Okabe H, Kurosawa K, Hatanaka N, Yoshitake J, Tagawa K. Protection of cellular and mitochondrial functions against anoxic damage by fructose in perfused liver. Biochim Biophys Acta 1991; 1098: 41.
39. Yamabe K, Shimizu S, Kamiike W, et al. Prevention of hypoxic liver cell necrosis by in vivo human bcl-2 gene transfection. Biochem Biophys Res Commun 1998; 243: 217.
40. Thurman RG, Bunzendahl H, Lemasters JJ. Role of sinusoidal lining cells in hepatic reperfusion injury following cold storage and transplantation. Semin Liver Dis 1993; 13: 93.
41. Bilbao G, Makheeva G, Contreras JL, et al. Genetic cytoprotection of human endothelial cells during the preservation time with an adenoviral vector encoding the anti-apoptotic human Bcl-2 gene. Transplant Proc 1999; in press.
42. Applebaum-Bowden D, Kobayashi J, Kashyap VS, et al. Hepatic lipase gene therapy in hepatic lipase-deficient mice. Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium. J Clin Invest 1996; 97: 799.
43. Drazan KE, Csete ME, da SX, et al. Hepatic function is preserved following liver-directed, adenovirus- mediated gene transfer. J Surg Res 1995; 59: 299.
44. Drazan KE, Olthoff KM, Wu L, Shen XD, Gelman A, Shaked A. Adenovirus-mediated gene transfer in the transplant setting: early events after orthotopic transplantation of liver allografts expressing TGF-betal. Transplantation 1996; 62: 1080.
45. Shaked A, Csete ME, Drazan KE, et al. Adenovirus-mediated gene transfer in the transplant setting. II. Successful expression of transferred cDNA in syngeneic liver grafts. Transplantation 1994; 57: 1508.
46. Shaked A, Csete ME, Shiraishi M, et al. Retroviral-mediated gene transfer into rat experimental liver transplant. Transplantation 1994; 57: 32.
47. Dematteo RP, Chu G, Ahn M, et al. Immunologic barriers to hepatic adenoviral gene therapy for transplantation. Transplantation 1997; 63: 315.
48. Chiu VK, Walsh CM, Liu CC, Reed JC, Clark WR. Bcl-2 blocks degranulation but not fas-based cell-mediated cytotoxicity. J Immunol 1995; 154: 2023.
49. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993; 151: 621.
50. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I- restricted CTLs. Nature 1998; 392: 86.
51. Rovere P, Vallinoto C, Bondanza A, et al. Cutting edge: bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 1998; 161: 4467.
52. Gapany C, Zhao M, Zimmermann A. The apoptosis protector, bcl-2 protein, is downregulated in bile duct epithelial cells of human liver allografts. J Hepatol 1997; 26: 535.
53. Kakizoe S, Yanaga K, Starzl TE, Demetris AJ. Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury. Hepatology 1990; 11: 932.
54. Markin RS, Wisecarver JL, Radio SJ, et al. Frozen sections evaluation of donor livers before transplantation. Transplantation 1993; 56: 1403.
55. Fukumori T, Ohkohchi N, Tsukamoto S, Satomi S. Why is fatty liver unsuitable for transplantation? Deterioration of mitochondrial ATP synthesis and sinusoidal structure during cold preservation of a liver with steatosis. Transplant Proc 1997; 29: 412.
56. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985; 229: 1390.
57. Katsumata M, Siegel RM, Louie DC, et al. Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci USA. 1992; 89: 11376.